PCSK9 Inhibitors: Georgia
March 1, 2018
A national data supplier reviewed PCSK9 inhibitor claims for managed care organizations in Georgia from January 2017 through December 2017.
Of health plans that received at least 200 claims for PCSK9 inhibitors, the following had the highest rates of rejections:
• Anthem – 80%
• Georgia State Health Benefit Plan – 54%
• Tricare Military Health SVC SYS – 53%
• Express Scripts – 49%
The following had the lowest rates of rejection:
• Cigna Healthcare – 18%
• Humana Health Plan – 13%
Tags: Cardiovascular, Prior Authorization
Categorized in: Report Cards